News and Insights >

Aluris Sciences News and Insights

The latest thinking from our team – insights on trends, challenges, and opportunities shaping life sciences manufacturing.

customer first solutions

Life Sciences | Combination and Drug Product Manufacturing | Lyophilization

GIRLS-IN-FACTORY2
Key Factors in Choosing the Right Biotech Contract Manufacturer

Uncategorised

This post lays out qualifying factors for choosing a biotech contract manufacturer, with a notable argument in favor of dedicated contract-manufacturing specialists over product companies selling excess capacity.
petri-dish-green
When Is the Right Time to Select a Biotech Contract Manufacturer (CDMO)?

Uncategorised

This post examines the pros and cons of engaging a contract manufacturer early, late, or after a product is already in production.
three-women-orange
Maximize Biotech Startup Growth Through Strategic Moves

Uncategorised

This post targets early-stage biotech founders short on cash and time, outlining strategies to extend runway and scale efficiently.
manufacture-lab-worker
How QSR-Compliant Medical Device Companies Can Switch to ISO 13485:2016

Uncategorised

This post explains the FDA’s move to harmonize its Quality System Regulation (QSR) with the international ISO 13485:2016 standard, and how device companies can prepare.
Capabilities
How to Compare Biotech Manufacturer Quotes — What You Need to Know

Uncategorised

This post explains how to make a true ‘apples-to-apples’ comparison of manufacturing quotes, since headline prices often hide meaningful differences in scope
four-people-glass-wall
Increasing Lyophilization Process Efficiency (Part 2 of a Series)

Uncategorised

The second post in the lyophilization series, focused on the elements that drive process efficiency and how efficiency gains affect both cost and diagnostic device performance.
lab-workers-with-salmon-folder
How to Overcome Your Protein Lyophilization Roadblocks

Uncategorised

This is one of the more technically substantive lyophilization posts, focused specifically on the difficulty of freeze-drying proteins (enzymes and antibodies) and how to overcome it.
Do You Know the Silent Killer of Biotech Supply Chain?

Uncategorised

This post frames capital depreciation as the ‘silent killer’ of biotech supply chains and argues that contract manufacturing neutralizes it by converting fixed costs to variable costs.
aluris logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.